Literature DB >> 9203447

Open-flow microperfusion of subcutaneous adipose tissue for on-line continuous ex vivo measurement of glucose concentration.

Z Trajanoski1, G A Brunner, L Schaupp, M Ellmerer, P Wach, T R Pieber, P Kotanko, F Skrabal.   

Abstract

OBJECTIVE: To evaluate a novel technique for on-line continuous glucose measurement in subcutaneous adipose tissue, and to investigate its accuracy for detection of hypoglycemia. RESEARCH DESIGN AND METHODS: The method combined an open-flow microperfusion of subcutaneous adipose tissue using a double lumen catheter and an extracorporeal sensor cell. An isotonic ion-free solution was perfused through the inner lumen of the catheter, equilibrated with the subcutaneous tissue fluid, and sampled through the outer lumen. The recovery was continuously monitored as the ratio between the measured sampled fluid conductivity and the subcutaneous tissue fluid conductivity (assumed to have a constant value of 1.28 S/m at 25 degrees C). Glucose concentration was calculated on-line from the measured glucose in the sampled fluid and the measured recovery in healthy volunteers during hyperglycemic glucose loads (n = 8), hypoglycemic hyperinsulinemic clamp (n = 6), and a 24-h monitoring period (n = 7).
RESULTS: Subcutaneous glucose concentrations in the fasting state were 94% of the plasma glucose concentrations in arterialized venous samples. According to the error grid analysis, 96.9% of the on-line measured subcutaneous glucose concentrations during hyperglycemia and 96.3% during hypoglycemia were in accurate or acceptable zones. The mean differences between the measured subcutaneous glucose and the actual plasma glucose concentration were -0.06-3.3 mmol/l (hyperglycemia), and -0.6-1.1 mmol/l (hypoglycemia).
CONCLUSIONS: By combining open-flow microperfusion, glucose sensor, and conductivity measurement, glucose concentration in the subcutaneous adipose tissue can be monitored on-line, extracorporeally, and continuously without any in vivo calibration, and gives accurate measurements during hyper- and hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203447     DOI: 10.2337/diacare.20.7.1114

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

Review 1.  Current challenges in bioequivalence, quality, and novel assessment technologies for topical products.

Authors:  Avraham Yacobi; Vinod P Shah; Edward D Bashaw; Eva Benfeldt; Barbara Davit; Derek Ganes; Tapash Ghosh; Isadore Kanfer; Gerald B Kasting; Lindsey Katz; Robert Lionberger; Guang Wei Lu; Howard I Maibach; Lynn K Pershing; Russell J Rackley; Andre Raw; Chinmay G Shukla; Kailas Thakker; Nathalie Wagner; Elizabeta Zovko; Majella E Lane
Journal:  Pharm Res       Date:  2014-01-07       Impact factor: 4.200

2.  Periodic extraction of interstitial fluid from the site of subcutaneous insulin infusion for the measurement of glucose: a novel single-port technique for the treatment of type 1 diabetes patients.

Authors:  Werner Regittnig; Stefan Lindpointner; Stefan Korsatko; Dina Tutkur; Manfred Bodenlenz; Thomas R Pieber
Journal:  Diabetes Technol Ther       Date:  2012-11-05       Impact factor: 6.118

3.  Comparison of open-flow microperfusion and microdialysis methodologies when sampling topically applied fentanyl and benzoic acid in human dermis ex vivo.

Authors:  R Holmgaard; E Benfeldt; J B Nielsen; C Gatschelhofer; J A Sorensen; C Höfferer; M Bodenlenz; T R Pieber; F Sinner
Journal:  Pharm Res       Date:  2012-03-15       Impact factor: 4.200

4.  An automated discontinuous venous blood sampling system for ex vivo glucose determination in humans.

Authors:  Roland Schaller; Franz Feichtner; Hans Köhler; Manfred Bodenlenz; Johannes Plank; Andrea Wutte; Julia K Mader; Martin Ellmerer; Reinhard Hainisch; Thomas R Pieber; Lukas Schaupp
Journal:  J Diabetes Sci Technol       Date:  2009-01

5.  Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes.

Authors:  Ting Shi; Dachao Li; Guoqing Li; Yiming Zhang; Kexin Xu; Luo Lu
Journal:  J Diabetes Res       Date:  2016-04-27       Impact factor: 4.011

6.  Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution.

Authors:  Manfred Bodenlenz; Christian Dragatin; Lisa Liebenberger; Bernd Tschapeller; Beate Boulgaropoulos; Thomas Augustin; Reingard Raml; Christina Gatschelhofer; Nathalie Wagner; Khaled Benkali; Francois Rony; Thomas Pieber; Frank Sinner
Journal:  Pharm Res       Date:  2016-06-06       Impact factor: 4.200

7.  Clinical evaluation of subcutaneous lactate measurement in patients after major cardiac surgery.

Authors:  Martin Ellmerer; Martin Haluzik; Jan Blaha; Jaromir Kremen; Stepan Svacina; Andreas Plasnik; Dimas Ikeoka; Manfred Bodenlenz; Lukas Schaupp; Johannes Plank; Thomas R Pieber
Journal:  Int J Endocrinol       Date:  2009-05-26       Impact factor: 3.257

8.  Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Ruthy Kaidar; Ofer Yodfat; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

9.  Glucose levels at the site of subcutaneous insulin administration and their relationship to plasma levels.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 17.152

10.  A Survey of Insulin-Dependent Diabetes-Part II: Control Methods.

Authors:  Daisuke Takahashi; Yang Xiao; Fei Hu
Journal:  Int J Telemed Appl       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.